Cronin, O., Forsyth, L., Goodman, K., Lewis, S. C., Keerie, C., Walker, A., . . . Wilkinson, D. (2019). Zoledronate in the prevention of Paget's (ZiPP): Protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget's disease of bone.
Citación estilo ChicagoCronin, Owen, et al. Zoledronate in the Prevention of Paget's (ZiPP): Protocol for a Randomised Trial of Genetic Testing and Targeted Zoledronic Acid Therapy to Prevent SQSTM1-mediated Paget's Disease of Bone. 2019.
Cita MLACronin, Owen, et al. Zoledronate in the Prevention of Paget's (ZiPP): Protocol for a Randomised Trial of Genetic Testing and Targeted Zoledronic Acid Therapy to Prevent SQSTM1-mediated Paget's Disease of Bone. 2019.